Blog

Karen Knudsen: Touring the Milken Center for Advancing the American Dream

Karen Knudsen/LinkedIn

Nov 20, 2024, 01:07

Karen Knudsen: Touring the Milken Center for Advancing the American Dream

Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS), shared a post on LinkedIn:

This week, I had the privilege of touring the Milken Center for Advancing the American Dream— an inspiring space dedicated to ensuring that opportunity, innovation, and education are accessible to everyone. I was reminded of how critical it is to empower individuals and communities to reach their full potential, which aligns deeply with my own commitment to advancing equity and impact in healthcare and beyond.

A highlight of my visit was spending quality time with my friend and visionary leader, Mike Milken. Mike’s boundless passion for creating a better future continues to inspire me. Whether it’s through his work in education, medical research, or economic empowerment, his dedication to making a difference is truly unparalleled. We talked about shared goals, bold ideas, and the ongoing work required to address some of the most pressing challenges of our time. I left feeling energized and even more motivated to contribute to solutions that drive meaningful change.

Thank you, Mike, and the Milken Institute team, for your incredible work and for hosting me—it was an unforgettable experience!

Karen E. Knudsen is the Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health. She also served as president for the Association of American Cancer Institutes (AACI) and on the board of directors of the American Association for Cancer Research (AACR). She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.